Addressing the burden of diabetes in the 21st century: Better care and primary prevention

Journal of the American Society of Nephrology

Volumn 14, Issue SUPPL. 2, 2003, Pages

  Engelgau, Michael M ^a,b   Narayan, K M Venkat ^a   Saaddine, Jinan B ^a   Vinicor, Frank ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; CONFERENCE PAPER; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ECONOMIC EVALUATION; EPIDEMIC; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; LIMB AMPUTATION; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PATIENT CARE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY CONTROL; SELF CARE; TECHNIQUE; TREATMENT PLANNING;

EID: 0037868137     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Zimmet P, Alberti KGMM, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414: 782-787, 2001
2. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431, 1998
3. Klein R, Klein BEK, Moss SE: Visual impairment in diabetes. Ophthalmology 91: 1-9, 1984
4. Wetterhall SF, Olson DR, DeStefano F, Stevenson JM, Ford ES, German RR, Will JC, Newman JM, Sepe SJ, Vinicor F: Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care 15: 960-967, 1992
5. Geiss LS, Engelgau M, Frazier E, Tierney E: Diabetes Surveillance, 1997, Atlanta GA, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 1997
6. Diabetes Health Economics Study Group: The Economics of Diabetes and Diabetes Care, Edited by Gruber W, Lander T, Leese B, Songer T, Williams R, International Diabetes Federation, 1997, http://www.pitt.edu/~tjs/diabecon.html
7. American Diabetes Association: Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21: 296-309, 1998
8. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
9. The UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317: 703-713, 1998
10. Early Treatment Diabetic Retinopathy Study Research Group: Early photocoagulation for diabetic retinopathy:ETDRS 9. Ophthalmology 98[Suppl 5]: 767-785, 1991
11. Littzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, Ford ES, Vinicor F: Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: A randomized controlled trial. Ann Inter Med 119: 36-41, 1993
12. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20: 614-620, 1997
13. ETDRS Investigators: Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study Report 14. JAMA 268: 1292-1300, 1992
14. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effects of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A 7-year follow-up study. Arch Intern Med 156: 286-289, 1996
15. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355: 253-259, 2000
16. Nichol KL, Wuorenma J, Von Sternberg T: Benefits of influenza vaccination for low-intermediate- and high-risk senior citizens. Arch Intern Med 158: 1769-1776, 1998
17. Blonde L, Dey J, Testa MA, Gutherie RD: Defining and measuring quality of diabetes care. Primary Care 26: 841-855, 1999
18. Lohr KN, Schroeder SA: A strategy for quality assurance in Medicare. N Engl J Med 322: 707-712, 1990
19. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA: The Diabetes Quality Improvement Project. Moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24: 1815-1819, 2001
20. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KMV: A diabetes report care for the United States: Quality of care in the 1990. Ann Intern Med 136: 565-574, 2002
21. Lee WRW, Lim HS, Thai AC, Chew WLS, Emmanuel S, Goh LG, Lau HC, Lee HC, Soon PC, Tambyah JA, Tan YT, Jorgensen LN, Chua A, Yeo JP: A window on the current status of diabetes mellitus in Singapore - the Diabcare-Singapore 1998 study. Singapore Med J 42: 501507, 2001
22. Raheja BS, Kapur A, Bhoraskar A, Sathe SR, Jorgensen LN, Moorthi SR, Pendsey S, Sahay BK: DiabCare Asia: India study: Diabetes care in India: Current status. J Assoc Physicians India 49: 717-722, 2001
23. Chuang LM, Tsai ST, Huang BY, Tai TY: The current state of diabetes management in Taiwan. Diabetes Res Clin Prac 54[Suppl]1: S55-S65, 2001
24. Narayan KMV, Gregg EW, Engelgau MM, Moore B, Thompson TJ, Williamson DF, Vinicor FV: Translation research for chronic disease: The case of diabetes. Diabetes Care 23: 1794-1798, 2000
25. Peterson KA, Vinicor F: Strategies to improve diabetes care delivery. J Fam Prac 47[Suppl]: S55-S62, 1998
26. Norris SL, Messina PJ, Caspersen CJ, Engelgau MM, Jack L, Riccio KM, Briss PA, Isham GJ, Glasgow RE, Garfield S, McCulloch D: Strategies for reducing morbidity and mortality from diabetes through health-care system interventions and diabetes self-management education in community settings. A report on recommendations of the task force on community preventive services. Mor Mort Wkly Rep 50[RR-16]: 1-16, 2001
27. Renders CM, Valk GD, Griffin SJ, Wagner EH, van Eijk JT, Assendelft WJ: Interventions to improve the management of diabetes in primary care, outpatient, and community settings. Diabetes Care 24: 1821-1833, 2001
28. Renders CM, Valk GD, Franse LV, Schellevis FG, van Eijk JT, van de Wal G: Long-term effectiveness of a quality improvement program for patients with type 2 diabetes in general practice. Diabetes Care 24: 1365-1370, 2001
29. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM: Self-management education for adults with type 2 diabetes. A meta-analysis of the effect on glycemic control. Diabetes Care 25: 1159-1171, 2002
30. Narayan KMV; Bowman BA, Engelgau MM: Prevention of type 2 diabetes. BMJ 323: 63-64, 2001
31. Tuomilehto J, Knowler WC, Zimmet P: Primary prevention of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 8: 339-353, 1992
32. Pan X, Li G, Hu Y, Wang J, Yang W, An Z, Hu Z, Lin J, Xiao J, Cao H, Liu P, Jiang X, Jiang Y, Wang J, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544, 1997
33. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainein H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, and Ussitupa M, for the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350, 2001
34. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 346: 393-403, 2002